Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-deficient Cancer Cells by Synthetic Lethality Induction

Name: Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-deficient Cancer Cells by Synthetic Lethality Induction
Uploaded: 2019/06/19
Duration: 11 min 59 s
Channel: Laura GUANTAY
Description: Conference recorded by Weconext in Rich media with video synced with slides and chapters

Laura GUANTAY